Evidence map›Paper›PMID 31360339›Full record

ArticleInternational journal of preventive medicine2019

Association of CYP1A1 M2 (A2455G) Polymorphism with Susceptibility to Breast Cancer in Mazandaran Province, Northern Iran: A Case-control Study.

Ghazaleh Khalili-Tanha, Ali Barzegar, Novin Nikbakhsh, Zarbakht Ansari-Pirsaraei

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of preventive medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. CYP1A1 M2 (A2455G) Polymorphism with Susceptibility to Breast Cancer.International journal of preventive medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ghazaleh Khalili-TanhaDepartment of Basic Sciences, Sari University of Agricultural Sciences and Natural Resources, Sari, Iran.
Ali BarzegarDepartment of Basic Sciences, Sari University of Agricultural Sciences and Natural Resources, Sari, Iran.
Novin NikbakhshDepartment of Surgery, Babol University of Medical Sciences, Babol, Iran.
Zarbakht Ansari-PirsaraeiDepartment of Animal Sciences, Sari University of Agricultural Sciences and Natural Resources, Sari, Iran.
Sari Agricultural Sciences and Natural Resources University · IRBabol University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer is one of the most frequent women malignancies in the world. The cytochrome P450 1A1 (

methodsNinety-six breast cancer patients with known clinicopathological characters and 110 healthy women as control were genotyped for

resultsThe analysis of

conclusionsThe results indicated that the M2 allelic genotypes were significantly associated neither with breast cancer risk nor with clinicopathological characteristics in Mazandaran province.

Indexed as

Breast neoplasmscytochrome P-450Iranpolymorphismrestriction fragment length

Identifiers

PMID31360339
PMCPMC6592102
OpenAlexW2961633345

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.